Vicarious Surgical Inc (NYSE:RBOT) Director Philip Liang Sells 12,500 Shares

Vicarious Surgical Inc (NYSE:RBOTGet Rating) Director Philip Liang sold 12,500 shares of the business’s stock in a transaction dated Friday, September 16th. The stock was sold at an average price of $3.81, for a total value of $47,625.00. Following the sale, the director now owns 1,196,577 shares in the company, valued at approximately $4,558,958.37. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Philip Liang also recently made the following trade(s):

  • On Wednesday, September 14th, Philip Liang sold 7,600 shares of Vicarious Surgical stock. The stock was sold at an average price of $4.28, for a total value of $32,528.00.
  • On Monday, September 12th, Philip Liang sold 11,943 shares of Vicarious Surgical stock. The stock was sold at an average price of $4.48, for a total value of $53,504.64.
  • On Friday, September 9th, Philip Liang sold 8,057 shares of Vicarious Surgical stock. The stock was sold at an average price of $4.43, for a total value of $35,692.51.
  • On Wednesday, August 10th, Philip Liang sold 3,891 shares of Vicarious Surgical stock. The stock was sold at an average price of $4.24, for a total value of $16,497.84.

Vicarious Surgical Trading Down 2.9 %

Shares of NYSE:RBOT opened at $3.73 on Friday. Vicarious Surgical Inc has a 12-month low of $2.82 and a 12-month high of $15.40. The company has a market capitalization of $454.00 million, a PE ratio of 18.65 and a beta of 0.75. The business has a 50 day moving average of $4.05 and a two-hundred day moving average of $4.15.

Vicarious Surgical (NYSE:RBOTGet Rating) last announced its quarterly earnings results on Monday, August 8th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). Equities research analysts predict that Vicarious Surgical Inc will post -0.62 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, BTIG Research decreased their target price on Vicarious Surgical from $8.00 to $7.00 and set a “buy” rating for the company in a report on Monday, July 18th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $11.60.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Wolverine Asset Management LLC lifted its holdings in Vicarious Surgical by 165.7% in the first quarter. Wolverine Asset Management LLC now owns 10,147 shares of the company’s stock valued at $51,000 after acquiring an additional 6,328 shares during the period. Rothschild Investment Corp IL increased its position in shares of Vicarious Surgical by 108.0% in the first quarter. Rothschild Investment Corp IL now owns 111,745 shares of the company’s stock valued at $566,000 after buying an additional 58,028 shares in the last quarter. Northern Trust Corp purchased a new stake in shares of Vicarious Surgical in the fourth quarter valued at approximately $664,000. Sciencast Management LP purchased a new stake in shares of Vicarious Surgical in the first quarter valued at approximately $177,000. Finally, NewEdge Wealth LLC purchased a new stake in shares of Vicarious Surgical in the first quarter valued at approximately $141,000. 51.79% of the stock is owned by institutional investors and hedge funds.

Vicarious Surgical Company Profile

(Get Rating)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Further Reading

Insider Buying and Selling by Quarter for Vicarious Surgical (NYSE:RBOT)

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.